CLBT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CLBT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cellebrite DI Ltd CLBT
Cellebrite DI CLBT 89 EV-to-EBITDA is 28.84 as of Aug. 13, 2026, which is 275% above its 10-year median of 7.69. GuruFocus rates CLBT with a GF Score™ of 89/100 and a GF Value™ of $16.08 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,958 Software companies, Cellebrite DI ranks worse than 79.06% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cellebrite DI's enterprise value is $3,397.7 Mil. Cellebrite DI's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $117.8 Mil. Therefore, Cellebrite DI's EV-to-EBITDA for today is 28.84.
The historical rank and industry rank for Cellebrite DI's EV-to-EBITDA or its related term are showing as below:
During the past 7 years, the highest EV-to-EBITDA of Cellebrite DI was 70.12. The lowest was -103.40. And the median was 7.69.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-08-13), Cellebrite DI's stock price is $15.25. Cellebrite DI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.280. Therefore, Cellebrite DI's PE Ratio (TTM) for today is 54.46.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Cellebrite DI (NAS:CLBT) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cellebrite DI's PE Ratio (TTM) for today is calculated as:
| PE Ratio (TTM) | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
| = | 15.25 | / | 0.280 | |
| = | 54.46 |
Cellebrite DI's share price for today is $15.25.
Cellebrite DI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.280.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Please read Which price ratio outperforms the enterprise multiple?
The historical data trend for Cellebrite DI's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Cellebrite DI Annual Data | ||||||||||||||||
| Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | Dec25 | |||||||||
| EV-to-EBITDA | Get a 7-Day Free Trial | 14.79 | 5.17 | -22.49 | -17.83 | 39.46 | ||||||||||
| Cellebrite DI Quarterly Data | ||||||||||||||||||||
| Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | Jun25 | Sep25 | Dec25 | Mar26 | |
| EV-to-EBITDA | Get a 7-Day Free Trial |
|
|
|
|
|
|
|
|
|
|
|
|
-16.21 | -14.02 | -16.28 | 39.46 | 25.73 | ||
For the Software - Infrastructure subindustry, Cellebrite DI's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Software industry and Technology sector, Cellebrite DI's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cellebrite DI's EV-to-EBITDA falls into.
Cellebrite DI's EV-to-EBITDA for today is calculated as:
| EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
| = | 3397.694 | / | 117.807 | |
| = | 28.84 |
Cellebrite DI's current Enterprise Value is $3,397.7 Mil.
Cellebrite DI's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $117.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Based on GuruFocus' analysis, Cellebrite DI stock appears to be undervalued. The current stock price of $15.25 is trading 5.2% below its estimated GF Value™ of $16.08. GuruFocus considers Cellebrite DI to be Fairly Valued.
Key valuation signals for CLBT:
No single metric tells the full story. See the CLBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.